Oridonin-induced mitochondria-dependent apoptosis in esophageal cancer cells by inhibiting PI3K/AKT/mTOR and Ras/Raf pathways

Journal of Cellular Biochemistry
Jin-Huan JiangJi-Ye Cai

Abstract

Oridonin, an active diterpenoid isolated from Rabdosia rubescens, has been reported for its antitumor activity on several cancers. However, its effect on human esophageal cancer remains unclear. In this study, we demonstrated that oridonin could inhibit the growth of human esophageal cancer cells both in vitro and in vivo. Oridonin not only suppressed the proliferation, but also induced cell cycle arrest and mitochondrial-mediated apoptosis in KYSE-30, KYSE-150, and EC9706 cells with dose-dependent manner. Further mechanism studies revealed that oridonin led cell cycle arrest in esophageal cancer cells via downregulating cell cycle-related proteins, such as cyclin B1 and CDK2, while upregulating p53 and p21. Oridonin also increased proapoptotic protein Bax and reduced antiapoptotic protein Bcl-2, as well as the increased expression of cleaved caspase-3, -8, and -9. In addition, oridonin treatment could significantly inhibit the PI3K/Akt/mTOR and Ras/Raf signaling pathway. In vivo results further demonstrated that oridonin treatment markedly inhibited tumor growth in the esophageal cancer xenograft mice model. Taken together, these results suggest that oridonin may be a potential anticancer agent for the treatment of esophageal ...Continue Reading

References

Jan 23, 2002·Cell Death and Differentiation·Guy S Salvesen
May 27, 2003·Apoptosis : an International Journal on Programmed Cell Death·J D LyA Lawen
Oct 4, 2003·Journal of Leukocyte Biology·Kate SchroderDavid A Hume
Apr 2, 2004·Cell·Peng LiXiaodong Wang
Dec 21, 2007·Journal of Pharmacological Sciences·Qiao CuiTakashi Ikejima
Dec 17, 2008·Theoretical Biology & Medical Modelling·Heather A HarringtonK C Tung
Jun 10, 2009·Journal of Medical Genetics·S GhavamiM Los
Jul 23, 2011·Chinese Medicine·Wen TanYitao Wang
Dec 7, 2011·Frontiers in Molecular Neuroscience·Jayashree Karar, Amit Maity
Mar 22, 2014·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Liang-Mou KuoTsong-Long Hwang
Apr 20, 2014·The Journal of Surgical Research·Fredrick J BohanonRavi S Radhakrishnan
Mar 10, 2015·Chemico-biological Interactions·Tsung-Yao LinChwen-Ming Shih
Aug 21, 2015·Drugs in R&D·Brice Ayissi Owona, Herman J Schluesener
Jan 26, 2016·CA: a Cancer Journal for Clinicians·Wanqing ChenJie He
May 6, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Dahong LiJinyi Xu
Apr 6, 2017·BMC Complementary and Alternative Medicine·Lili TianGuofu Zhu
Sep 25, 2017·European Journal of Pharmacology·Han WangFuxiang Chen
Feb 9, 2018·Breast Cancer Research and Treatment·Ricardo L B CostaWilliam J Gradishar
Feb 13, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Jing YangJuan Xia
Mar 9, 2018·European Journal of Pharmacology·Weichen HuangJiang Liang
Apr 21, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Jie YingYu Lu
Apr 21, 2018·Current Opinion in Pharmacology·Timothy M HallKelly A Whelan

❮ Previous
Next ❯

Citations

Sep 6, 2019·Lasers in Medical Science·Zhenlin WangLixia Chen
Oct 30, 2019·Mini Reviews in Medicinal Chemistry·Xu HuDahong Li
Aug 17, 2019·Cancers·Bahar Shamloo, Sinem Usluer
Jun 10, 2020·BMC Complementary Medicine and Therapies·Yangyang GuoLinxiao Sun
Sep 29, 2020·Cancer Management and Research·Bo KouWei Liu
Dec 24, 2019·Seminars in Cancer Biology·Devesh TewariAnupam Bishayee
Feb 7, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Nurul Akmaryanti AbdullahNoraina Muhamad Zakuan
Mar 6, 2021·Frontiers in Oncology·Plabon Kumar DasAlfred K Lam
May 5, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Olaf-Georg Issinger, Barbara Guerra
May 18, 2021·Frontiers in Oncology·Yong XiaYoung Do Jung
Aug 29, 2021·Medicinal Research Reviews·Kritika LaxmikeshavNagula Shankaraiah
Nov 27, 2021·Integrative Cancer Therapies·Luchang CaoJie Li

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cell Cycle Pathways

Cell cycle is a complex process regulated by several signal transduction pathways and enzymes. Here is the latest research on regulation of cell cycle and cell cycle pathways.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Related Papers

Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
Jing YangJuan Xia
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society
Shixin XiaHonglian Guan
Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
Xiao-Xue DuYu-Xian Bai
© 2022 Meta ULC. All rights reserved